Month: May 2024
2106 posts
Formosa Pharmaceuticals Announces Licensing Agreement with Tabuk Pharmaceuticals, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
TAIPEI, May 9, 2024 /PRNewswire/ — Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TWO) announced…









